DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis

Shargie, Estifanos B.; Lindtjørn, Bernt
January 2005
BMC Public Health;2005, Vol. 5 Issue 1, p62
Academic Journal
Background: DOTS as a strategy was introduced to the tuberculosis control programme in Southern region of Ethiopia in 1996. The impact of the programme on treatment outcomes and the trend in the service coverage for tuberculosis has not been assessed ever since. The aim of the study was to assess trends in the expansion of DOTS and treatment outcomes for tuberculosis in Hadiya zone in Southern Ethiopia. Methods: 19,971 tuberculosis patients registered for treatment in 41 treatment centres in Hadiya zone between 1994 and 2001 were included in the study. The data were collected from the unit tuberculosis registers. For each patient, we recorded information on demographic characteristics, treatment centre, year of treatment, disease category, treatment given, follow-up and treatment outcomes. We also checked the year when DOTS was introduced to the treatment centre. Results: Population coverage by DOTS reached 75% in 2001, and the proportion of patients treated with short course chemotherapy increased from 7% in 1994 to 97% in 2001. Treatment success for smear-positive tuberculosis rose from 38% to 73% in 2000, default rate declined from 38% to 18%, and treatment failure declined from 5% to 1%. Being female patient, age 15-24 years, smear positive pulmonary tuberculosis, treatment with short course chemotherapy, and treatment at peripheral centres were associated with higher treatment success and lower defaulter rates. Conclusion: The introduction and expansion of DOTS in Hadiya has led to a significant increase in treatment success and decrease in default and failure rates. The smaller institutions exhibited better treatment outcomes compared to the larger ones including the zonal hospital. We identified many patients with missing information in the unit registers and this issue needs to be addressed. Further studies are recommended to see the impact of the programme on the prevalence and incidence of tuberculosis.


Related Articles

  • Adjuvant Immunotherapy of Extensively Drug-Resistant Tuberculosis (XDR-TB) in Ukraine. Yurchenko, Larisa V.; Sokolenko, Nina I.; Vihrova, Lyudmila A.; Pylypchuk, Volodymyr S.; Frolov, Valery M.; Kutsyna, Galyna A.; Prihoda, Nathalia D.; Arjanov, Olga V. // Current Research in Tuberculosis;2009, Vol. 1 Issue 1, p9 

    Conventional TB chemotherapy success rates are very low in patients with Extensively Drug-Resistant Tuberculosis (XDR-TB). We treated twelve XDR-TB individuals, seven of which in addition to standard Anti-TB Therapy (ATT) received Immunoxel (Dzherelo), Svitanokand Lisorm over-the-counter herbal...

  • Watch TB Patients Swallow Their Medications. Ruppert, Rebecca Ann // RN;Oct2006, Vol. 69 Issue 10, p45 

    The article offers information on the concept of directly observed therapy (DOT). DOT is the standard of medication delivery for patients with tuberculosis to ensure their compliance with the medication and to prevent the spread of infection and reduce multidrug resistance. Patients are watched...

  • Tuberculosis and related bacteria.  // Mayo Clinic Health Letter;Jul2013, Vol. 31 Issue 7, p4 

    This article presents information on tuberculosis (TB) and myobacteria related to it. TB caused 1.4 million deaths worldwide in 2011. There are several types of myobacteria that are related to TB which are not transmitted from person to person. These include myobacterium avium complex,...

  • Cerebral tuberculoma as a manifestation of paradoxical reaction in patients with pulmonary and extrapulmonary tuberculosis. Das, Anirban; Das, Sibes Kumar; Mandal, Abhijit; Halder, Arup Kumar // Journal of Neurosciences in Rural Practice;Sep-Dec2012, Vol. 3 Issue 3, p350 

    Expansion of cerebral tuberculomas or their new appearance as a manifestation of paradoxical reaction in patients under antituberculous chemotherapy is well documented. Distinguishing paradoxical reaction from disease progression or treatment failure is an important issue in tuberculosis...

  • Expanded Polyfunctional T Cell Response to Mycobacterial Antigens in TB Disease and Contraction Post-Treatment. Young, James M.; Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Sutherland, Jayne S. // PLoS ONE;2010, Vol. 5 Issue 6, p1 

    Background: T cells producing multiple factors have been shown to be required for protection from disease progression in HIV but we have recently shown this not to be the case in TB. Subjects with active disease had a greater proportion of polyfunctional cells responding to ESAT-6/CFP-10...

  • Nihilism and Pragmatism in Tuberculosis Control. Farmer, Paul; Nardell, Edward // American Journal of Public Health;Jul98, Vol. 88 Issue 7, p1014 

    The article presents the editor's views on the debate related to efforts to control tuberculosis (TB) through structural social reforms or through a targeted public health interventions. This debate rages on from the mid century development of effective chemotherapy for TB. And indeed, the...

  • Tuberculosis of the knee. Lidder, Surjit; Lang, Kathryn; Haroon, Mallick; Shahidi, Mitra; El-Guindi, Magdi // Orthopedic Reviews;2009, Vol. 1, p64 

    Extrapulmonary manifestations of tuberculosis are reported in less than one in five cases with the knee affected in 8% after the spine and hip. We report a case of isolated highly erosive tuberculosis of the knee presenting in a previously fit Vietnamese woman. The difficulties of diagnosis,...

  • Adherence to Tuberculosis Treatment among Migrant Pulmonary Tuberculosis Patients in Shandong, China: A Quantitative Survey Study. Chengchao Zhou; Jie Chu; Jinan Liu; Ruoyan Gai Tobe; Hong Gen; Xingzhou Wang; Wengui Zheng; Lingzhong Xu // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Adherence to TB treatment is the most important requirement for efficient TB control. Migrant TB patients' ''migratory'' nature affects the adherence negatively, which presents an important barrier for National TB Control Program in China. Therefore, TB control among migrants is of high...

  • Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Sacchettini, James C.; Rubin, Eric J.; Freundlich, Joel S. // Nature Reviews Microbiology;Jan2008, Vol. 6 Issue 1, p41 

    Tuberculosis (TB) claims a life every 10 seconds and global mortality rates are increasing despite the use of chemotherapy. But why have we not progressed towards the eradication of the disease? There is no simple answer, although apathy, politics, poverty and our inability to fight the chronic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics